MONTREAL ― The International AIDS Society (IAS) has pledged that it "will not go back to business as usual" after hundreds of delegates to its International AIDS Society (IAS) Conference 2022, held in ...
ViiV Healthcare’s combination injectable human immunodeficiency virus (HIV) medication was preferred over a daily tablet in treatment-naïve patients in a Phase IIIb trial. A global specialist in HIV ...
There is still no effective vaccine or cure for HIV. Scientists are considering options ranging from longer-term antiretroviral therapy (ART) that space out injections by several years to long-lasting ...
On Sunday 21 July, from 18:00 – 18:45 (CDT), leaders in the HIV field will brief journalists just before the start of the 10 th IAS Conference on HIV Science (IAS 2019) opening session on the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results